Skip to content

Clinical trials

Diabetes Mellitus, Type 1 trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Country / region: Portugal Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20102
20131
20152
20172
20211
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
Eli Lilly and Company2
Ixaka Ltd2
Association for Innovation and Biomedical Research on Light and Image1
Boehringer Ingelheim1
Pfizer1
Unidade Local de Saúde de Coimbra, EPE1
Universidade Nova de Lisboa1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 112
Diabetes Mellitus6
Diabetes Mellitus, Type 25
Cardiovascular Diseases2
Chronic Limb-Threatening Ischemia2
Peripheral Arterial Disease2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.